Stock & Company Details
Agilent Technologies Inc. $A
Price:
N/A
N/A
282M
$47B
52 Week High:
N/A
10 Day Average Volume:
N/A
33.81
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
A technical indicators
Latest Agilent Technologies Inc. (A) indicator readings as of 2026-10-09.
A's 14-day RSI is 62.2, in neutral territory. At $170.54 it is trading 27.6% above its 200-day moving average of $133.63, and above its 50-day average of $155.58. Price sits in the middle of its Bollinger Bands ($149.08 to $181.83). ADX reads 39.3, indicating a trending market.
A backtested strategy results
How 4 rule-based strategies performed on Agilent Technologies Inc. (A) over recent history, last backtested 2026-10-07. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +1.6% | 40% | 10 | -41.3% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +18.3% | 41% | 27 | -34.6% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -11.4% | 41% | 29 | -30.9% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +11.8% | 71% | 24 | -22.3% |
Overview
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
Finance Bot
Ask your questions
Start by typing a question below.
